Active Ingredient(s): Maralixibat Chloride
FDA Approved: * September 29, 2021
Pharm Company: * MIRUM
Category: Genetic Disorders

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Livmarli Overview

Maralixibat chloride, sold under the brand name Livmarli, is a medication used to treat cholestatic pruritus in people with Alagille syndrome.[1] Maralixibat chloride is an ileal bile acid transporter (IBAT) inhibitor.[1] Maralixibat was approved for medical use in the United States in September 2021.[1][2][3] Contents 1 History 2 Names 3 References 4 External links History Maralixibat was granted orphan dr...

Read more Livmarli Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Livmarli Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Maralixibat Chloride
  • Solution: 9.5mg/ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Maralixibat Chloride or a similar ingredient: (1 result)